Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Federal Trade Commission
Johnson and Johnson
US Department of Justice
AstraZeneca
Merck
Julphar
Chubb
UBS
QuintilesIMS

Generated: October 17, 2017

DrugPatentWatch Database Preview

METHYLPHENIDATE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Methylphenidate Hydrochloride, and what generic Methylphenidate Hydrochloride alternatives are available?

Methylphenidate Hydrochloride is a drug marketed by Mallinckrodt, Tris Pharma Inc, Novel Labs Inc, Able, Impax Labs Inc, Teva Pharms, Mallinckrodt Inc, Watson Labs, Sun Pharm Inds Inc, Ascent Pharms Inc, Actavis Labs Fl Inc, Actavis Elizabeth, Mylan Pharms Inc, Osmotica, Ucb Inc, Barr Labs Inc, Abhai Inc, Cnty Line Pharms, Breckenridge Pharm, Tedor Pharma Inc, Mayne Pharma, Abhai Llc, Vintage Pharms, and Kremers Urban Pharms. and is included in thirty-eight NDAs.

The generic ingredient in METHYLPHENIDATE HYDROCHLORIDE is methylphenidate hydrochloride. There are thirty-one drug master file entries for this compound. Thirty-six suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the methylphenidate hydrochloride profile page.

Summary for Tradename: METHYLPHENIDATE HYDROCHLORIDE

US Patents:0
Applicants:24
NDAs:38
Suppliers / Packagers: see list29
Bulk Api Vendors: see list28
Clinical Trials: see list2,564
Patent Applications: see list2,430
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:METHYLPHENIDATE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: METHYLPHENIDATE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078458-001Dec 1, 2011AB1RXNoNo► Subscribe► Subscribe► Subscribe
Abhai Llc
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET, EXTENDED RELEASE;ORAL207488-002Jun 9, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET;ORAL040321-002Feb 5, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET, CHEWABLE;ORAL204115-002Feb 25, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt Inc
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL203583-001Sep 29, 2015AB2RXNoNo► Subscribe► Subscribe► Subscribe
Osmotica
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET, EXTENDED RELEASE;ORAL205327-003Jul 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Abhai Inc
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET;ORAL206932-002May 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET, EXTENDED RELEASE;ORAL206726-003Oct 21, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Vintage Pharms
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET;ORAL202892-001Sep 23, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Osmotica
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET, EXTENDED RELEASE;ORAL205327-004Jul 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Moodys
Merck
Boehringer Ingelheim
Covington
Mallinckrodt
Daiichi Sankyo
AstraZeneca
Baxter
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot